Clindac A Gel (Clindamycin + Nicotinamide) – Nottingham, East Midlands, United Kingdom (2026)
Visit
Website: unnatipharmax.com
Phone: +91 82650 41513
Email: Unnatipharmax@gmail.com
PRODUCT NAME
Brand Name: Clindac A Gel
Generic Name: Clindamycin Phosphate + Nicotinamide Gel
Dosage Form: Topical Gel
Therapeutic Category: Topical Antibiotic & Anti-Inflammatory Acne Treatment
PRODUCT DETAILS
Clindac A Gel combines Clindamycin Phosphate, a topical antibiotic, with Nicotinamide (Niacinamide), an anti-inflammatory agent, to help manage acne vulgaris. The formulation helps reduce acne-causing bacteria, decreases inflammation, and supports clearer-looking skin by reducing pimples, redness, and swelling.
It is commonly prescribed for:
- Acne Vulgaris
- Inflammatory Acne
- Papules and Pustules
- Facial Acne
- Oily & Acne-Prone Skin
- Mild to Moderate Acne
Use only as directed by a qualified healthcare professional.
PRODUCT SPECIFICATION
| Brand Name | Clindac A Gel |
| Generic Name | Clindamycin Phosphate + Nicotinamide |
| Dosage Form | Topical Gel |
| Route | External Use Only |
| Therapeutic Class | Topical Antibiotic + Anti-Inflammatory |
| Packaging | Tube |
| Storage | Store below 25°C in a cool, dry place |
| Prescription | May be required depending on local regulations |
| Manufactured In | India |
| Export Availability | Worldwide (where legally permitted) |
KEY FEATURES
- Dual-action formula with Clindamycin and Nicotinamide
- Helps reduce acne-causing bacteria
- Reduces inflammation, redness, and swelling
- Supports clearer-looking skin
- Non-greasy, easy-to-apply gel formulation
- Suitable for mild to moderate inflammatory acne
- Manufactured in WHO-GMP compliant facilities
- Secure packaging for international export
- Available for retail, wholesale, and bulk supply
- Competitive export pricing
INDUSTRY UPDATE
The global acne treatment market continues to grow in 2026 as awareness of evidence-based skincare and dermatology services increases. Combination topical therapies containing antibiotics and anti-inflammatory ingredients remain widely prescribed for selected patients with inflammatory acne.
Current market trends include:
- Growing demand for dermatologist-recommended acne treatments
- Increased use of combination topical therapies for inflammatory acne
- Expansion of teledermatology consultations across the UK and other international markets
- Rising preference for quality-assured generic dermatology products
- Continued emphasis on responsible antibiotic use and personalized acne management plans to support effective long-term treatment outcomes.

FAQ 1: Why is Clindac A Gel's combination formulation (Clindamycin + Nicotinamide) superior to Clindamycin alone for Nottingham's acne patients?

FAQ 2: How does Nottingham's large student population drive demand for Clindac A Gel?

FAQ 3: How does Nottingham's NHS primary care landscape affect Clindac A Gel access and prescribing for the city's acne patients?

FAQ 4: How does Nottingham's growing Yemeni community — recently arrived refugees — engage with acne and skin care access?

FAQ 5: What practical application guidance does Nottingham University Hospitals give for Clindac A Gel to maximise efficacy and minimise antibiotic resistance risk?
Website
Email Id
Contact Number
+91-8265041513
Clindac-A-Gel-Clindamycin -Nicotinamide-Nottingham